Tracking Quality of Life in Tremor Patients Treated With Radiosurgery
Follows adults with essential or Parkinsonian tremor treated with radiosurgery.
Key facts
- Who runs it
- Vanderbilt University Medical Center
- Where
- Nashville, United StatesSee the site
- Trial code
- Registry title
- Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 21 Feb 2013
- Expected to end
- Sept 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- Questionnaires / Observational Assessments
- Record updated
- 16 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with essential tremor or Parkinsonian tremor that medicine alone does not control well, who prefer radiation treatment.
- Age
- At least 18 years old
- Sex
- All sexes can join
- Disease stage
- Essential tremor or Parkinsonian tremor, confirmed by a neurologist, that is not well enough controlled by medication alone
- Earlier treatment
- People who had a surgical thalamotomy cannot join. A deep brain stimulator on the other side of the brain is allowed. Radiation to the thalamus before is a reason not to join.
Main reasons for not taking part
- Cannot safely have radiation to the head, for example earlier radiation to the thalamus
- Cannot have an MRI of the brain
- Had a surgical thalamotomy before
- Expected life span of less than 1 year
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Must be certified by a neurologist as having essential tremor or Parkinsonian tremor that is insufficiently controlled by medication alone
- Preference to receive radiation treatment for tremor treatment, rather than surgical DBS implantation or surgical thalamotomy
- At least 18 years old
Who cannot take part
- Contraindications to cranial radiation (such as prior radiation to the thalamus)
- Prior surgical thalamotomy treatment (but contralateral deep brain stimulator [DBS] is permitted)
- Inability to have a MRI of the brain
- Estimated life expectancy less than 1 year
Where in United States
- Vanderbilt University Medical CenterNashville, United StatesContact: Send Patient Referrals to Movement Disorder CoordinatorsTaking people
About the trial
What the trial wants to find out
The purpose of this study is to determine the changes in quality of life and degree of tremor for patients with essential tremor or Parkinsonian tremor who are treated by stereotactic radiosurgery (SRS). This is a questionnaire-based study. Please see Detailed Description below for more information.
The 2 groups in the trial
- Essential Tremor
Patients with severe, medication-refractory Essential Tremor
Treatment: Questionnaires / Observational Assessments
- Parkinsonian Tremor
Patients with severe, medication-refractory, tremor-dominant Parkinsons
Treatment: Questionnaires / Observational Assessments
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- Plain-language title
- Tracking Quality of Life in Tremor Patients Treated With RadiosurgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery.International journal of radiation oncology, biology, physics, 2022
- Record updated
- 16 September 2026